The Emirates Society of Ophthalmology (ESO) has inaugurated the 22nd edition of its annual conference, ESO 2025, at Hilton Abu Dhabi Yas Island.
The three-day event, held under the patronage of Sheikha Dr. Noura Al Qassimi, President of ESO and the Emirates Medical Association, brings together leading ophthalmologists, researchers, and health experts to discuss advancements in eye care and ophthalmic research.
A key highlight of the opening day was the signing of a strategic collaboration between ESO and Théa Pharma, alongside the launch of ESTBEC (Epidemiology Study Before Eye Complications), the UAE’s first initiative of its kind. ESTBEC aims to advance research, enhance patient care, and map the prevalence of ocular diseases nationwide.
Sheikha Dr. Noura Al Qassimi described the initiative as a significant step in ophthalmic research, supporting early detection and improved management of vision-related conditions. Carol El Ajouz, General Manager of Théa Pharma Middle East, highlighted the collaboration’s role in identifying ocular disease trends, aligning with the UAE’s Vision 2030 for a healthier future.
Dr. Omnia Hamam, Consultant Ophthalmologist at Sheikh Shakhbout Medical City, called ESTBEC a milestone in early eye disease detection. Meanwhile, Dr. Mona Marwan, Cornea and Refractive Surgery Specialist, outlined screening programmes targeting keratoconus, glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration.
ESO 2025 continues with expert-led discussions and initiatives that will shape the future of ophthalmic care in the region.
News Source: Emirates News Agency
